The Connect® Lymphoma Disease Registry is a study in the United States to collect information about people with non-Hodgkin lymphoma (NHL). This includes two types: diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). This study is prospective, meaning it follows participants over time without changing their treatment. It is observational, so researchers only watch and learn, not give new treatments. They'll look at how patients are treated in real-life settings, how they respond, and their quality of life. Participants' health details and social support will be recorded.
- Duration: Participation follows routine care, no new treatments given.
- Commitment: Participants will complete surveys about their health and social support.
- Eligibility: Must be 18+, have specific NHL types, and previously treated.
No new drugs will be used in this study, and patients will receive standard treatments. If you have NHL and want to help researchers understand more about this condition, you might consider joining. Participants must be able to provide information about past treatments and be willing to complete some questionnaires.